Ozempic MDL 3094 CMOs
Below are links to the case management orders (CMOs) entered in the Ozempic lawsuit MDL 3094. Ozempic lawsuits have been filed around the nation alleging that the drug caused bowel obstructions and other GI disorders. Case management orders are an excellent way to stay up to date on the status of the Ozempic lawsuits that are part of MDL 3094. Bookmark this page so that you can check in on the latest Ozempic lawsuit updates.
02/02/2024: JPML Transfer Order – Creation of MDL 3094
02/16/2024: CMO 2 – Pro Hac Vice Appearances in Ozempic Lawsuits
04/23/2024: CMO 3 – Initial Ozempic Leadership Appointments
04/23/2024: CMO 4 – Preservation Order
04/26/2024: CMO 5 – Ozempic Science Day (Vacated)
05/08/2024: CMO 6 – Ozempic Leadership Expanded
06/06/2024: CMO 7 – Status Conference on June 10, 2024, with Honorable Karen Marston
06/10/2024: CMO 8 – Pro Hac Vice
06/25/2024: CMO 9 – Privilege Logging Order
Ozempic Lawsuit Information
For more information on each Ozempic case management order and the status of the Ozempic lawsuits in MDL 3094, visit our page on Ozempic Lawsuit MDL 3094. For a free Ozempic lawsuit consultation with one of our Ozempic attorneys, please call 202-792-7927.
